Inputs: momentum, trendVelocity
Momentum 94/100 confirmed by trend velocity 100/100.
Prediction result · Ensemble engineUpdated 3:55 AM
CRLCharles River Laboratories International, Inc. stock price outlook
$359.41-4.44% since prev closeNeutral
Charles River Laboratories International, Inc. (CRL) is trading at $359.41, down 4.44% since the previous close and +4.07% over the past week. Price sits above its 50-day average by 19.05%, with price momentum at 94/100 and trend velocity at 100/100. Sentiment across 4 recent headlines reads net constructive at 59/100. Volatility risk is moderate (69/100) and the stock is 91% of the way up its 52-week range. The weighted factor score lands at 62/100 — a neutral signal. Research only, not investment advice.
Universal leanmarket
CRL
Charles River Laboratories International, Inc.
$359.41-4.44%
LEANNEUTRAL / wait for cleaner tape
WHY
- Charles River Laboratories International, Inc. (CRL) is trading at $359.41, down 4.44% since the previous close and +4.07% over the past week. Price sits above its 50-day average by 19.05%, with price momentum at 94/100 and trend velocity at 100/100. Sentiment across 4 recent headlines reads net constructive at 59/100. Volatility risk is moderate (69/100) and the stock is 91% of the way up its 52-week range. The weighted factor score lands at 62/100 — a neutral signal. Research only, not investment advice.
- Bull input: Momentum 94/100 confirmed by trend velocity 100/100.
- Bear input: Composite oscillator at 97 — stretched zone, pullback risk.
RISK
Signals are model output from public data, not personalized investment advice.
INVALIDATE
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · Playable
live data
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
4 relevant headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
News Sentiment59/100
Price Momentum94/100
Trend Velocity100/100
Volatility Risk69/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
Signal Explanation
Charles River Laboratories International, Inc. (CRL) is trading at $359.41, down 4.44% since the previous close and +4.07% over the past week. Price sits above its 50-day average by 19.05%, with price momentum at 94/100 and trend velocity at 100/100. Sentiment across 4 recent headlines reads net constructive at 59/100. Volatility risk is moderate (69/100) and the stock is 91% of the way up its 52-week range. The weighted factor score lands at 62/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on CRL
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgePlayableNeutral
Inputs: newsSentiment, dayChange
Sentiment 59/100 + price -4.4% are both mid-range.
Inputs: unusualVolume, dayChange
Volume read 47/100 with price drift -4.4% — no clear footprint.
Inputs: volatilityRisk, momentum
Vol regime 69/100 is mid-range — no edge.
Inputs: pctOfRange, trendVelocity
Near range top — needs fresh catalyst to break out.
Inputs: newsSentiment, weekChange
Sentiment 59/100 vs week change 4.1% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price 19.1% over 50d SMA with momentum confirming — uptrend intact.
Inputs: momentum, trendVelocity
Composite oscillator at 97 — stretched zone, pullback risk.
Inputs: momentum, dayChange, vsSma50
Momentum 94/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 59/100 and weekly change 4.1% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 47/100 does not show a dry-up signal.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 69/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Price is at a range extreme, but the tape is not confirming the breakout.
Inputs: newsSentiment, momentum, weekChange
Sentiment 59/100 and momentum 94/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
Price is above the 50d SMA and both momentum and trend velocity are holding up.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 97 does not show a rebound edge.
Why the ensemble agrees
- Price is at a range extreme, but the tape is not confirming the breakout.
- Near range top — needs fresh catalyst to break out.
- Sentiment 59/100 + price -4.4% are both mid-range.
Counter-trees
- Momentum 94/100 confirmed by trend velocity 100/100.
- Price 19.1% over 50d SMA with momentum confirming — uptrend intact.
Bull Case
- Momentum 94/100 confirmed by trend velocity 100/100.
- Price 19.1% over 50d SMA with momentum confirming — uptrend intact.
- Price is above the 50d SMA and both momentum and trend velocity are holding up.
Bear Case
- Composite oscillator at 97 — stretched zone, pullback risk.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Yahoo Finance59
Carel (BIT:CRL) Stock May Be Overvalued On Its Earnings Profile
9/18/2026, 6:12:00 PM
MSN52
LH vs. CRL: Which stock is the better value option?
6/15/2026, 8:40:00 AM
Yahoo Finance57
Charles River (CRL) Stock Could Be 27% Overvalued As Preclinical FDA Collaboration Starts
10/30/2026, 12:09:00 AM
Nasdaq69
Here's Why Charles River Laboratories (CRL) is a Great Momentum Stock to Buy
1/14/2026, 4:00:00 PM
Key stats
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Market cap
- $17.16B
- 52-week range
- $379.63/$146.195
- Volume
- 1,503,897
- Avg volume
- 349,040
- Analyst 1-yr target
- $330.00
- Exchange
- NYSE
Source: Nasdaq public quote data. Research only.
Insider trades
0 buys · 1 sells by CRL insiders (SEC Form 4 filings)
- SELL Parisotto Shannon M CEVP, Disc & Safety Assessment · 2026-10-23$743K
Earnings Intelligence
Next
Nov 4, 2026
Estimate
$2.98
Actual
$3.02
- • Last report Aug 5, 2026 (Jun 2026): EPS $3.02 vs $2.72 expected, +11.03% surprise.
- • Beat estimates in 4 of the last 4 quarters.
- • Next report expected Nov 4, 2026, consensus EPS $2.98 (Zacks estimate via Nasdaq; the company may confirm a different date).
Risk Warnings
- • Signals are model output from public data, not personalized investment advice.
- • High volatility — position sizing and stops matter more here.
- • Confirm liquidity, spreads, and your own thesis before acting.
CRL questions
What is the MarketPicks AI signal for Charles River Laboratories International, Inc. stock (CRL)?
As of Nov 1, 10:55 PM ET, the ensemble reads neutral on CRL — no consensus — 12 of 16 bots holding, with 3 bull, 1 bear and 12 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest CRL price on MarketPicks?
CRL was $359.41 on the latest quote (Nov 1, 10:55 PM ET), -4.44% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for CRL mean?
Scores run from 0 to 100, with 50 neutral. CRL shows momentum 94/100, trend velocity 100/100 and volatility risk 69/100, with news sentiment at 59/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.